S&P Futures
2,476.50
+2.50 (+0.10%)Dow Futures
21,584.00
+24.00 (+0.11%)
| Previous Close | 26.15 |
| Open | 26.43 |
| Bid | 13.80 x 100 |
| Ask | 0.00 x |
| Day's Range | 26.25 - 26.87 |
| 52 Week Range | 13.81 - 27.99 |
| Volume | 23,597 |
| Avg. Volume | 27,815 |
| Market Cap | 144.91M |
| Beta | 0.98 |
| PE Ratio (TTM) | 17.81 |
| EPS (TTM) | 1.49 |
| Earnings Date | Jul 24, 2017 - Jul 28, 2017 |
| Dividend & Yield | 0.60 (2.29%) |
| Ex-Dividend Date | 2017-05-04 |
| 1y Target Est | 32.00 |
- Capital Cube•last month
ETFs with exposure to Psychemedics Corp. : June 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•2 months agoPsychemedics Corp. :PMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017
Categories: Yahoo FinanceGet free summary analysis Psychemedics Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, RadNet, Inc., Trovagene, Inc., CombiMatrix Corporation and Interleukin Genetics, Inc. (NEO-US, LH-US, DGX-US, RDNT-US, TROV-US, CBMX-US ... Read more (Read more...)
- Associated Press•3 months ago
Psychemedics posts 1Q profit
On a per-share basis, the Acton, Massachusetts-based company said it had profit of 27 cents. The drug testing company posted revenue of $10.2 million in the period. Psychemedics shares have decreased 16 ...
